SEC Form D · Amendment · filed May 12, 2017
DalCor Pharmaceuticals US, LLC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (23)
D. M. Dixon · Montreal, Quebec, CanadaExec · DirectorRody M. Yared · Montreal, Quebec, CanadaDirectorRobert Mcneil · San Mateo, CAExec · Director · PromoterMark M. Smith · Montreal, Quebec, CanadaDirectorLouise M. Proulx · Montreal, Quebec, CanadaExecThomas M. Birch · Montreal, Quebec, CanadaDirectorLaurence M. Rulleau · Montreal, Quebec, CanadaDirectorBryan E. Roberts · Palo Alto, CADirectorRichard W. Stone · Denver, CODirectorPeter Mcdonnell · Winnetka, ILExec · DirectorCamille D. Samuels · Palo Alto, CAExecJeffrey E. Bennis · Denver, CODirectorJeffrey Krol · Winnetka, ILDirectorJay K. Alexander · Denver, COExec · Director · PromoterGa?Tan M. Gravel · Montreal, Quebec, CanadaDirectorLarry A. Lance · Denver, CODirectorPaul E. Andrews · Denver, COExec · Director · PromoterRobert P. Kocher · Palo Alto, CAExecThomas Scott · Winnetka, ILExec · DirectorKane Street Long GP LLC · New York, NYDirectorKane Street Capital Management LLC · New York, NYDirectorMichael C. Blue · Ann Arbor, MIDirectorGa?Tan M. Gravel · Montreal, Quebec, CanadaDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗